Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of AlloJoin for knee osteoarthritis
CTR20232083Phase 3Active
- Sponsor
- Cellular Biomedicine Group
- Start
- Jul 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of allogeneic adipose-derived stromal/stem cells in knee osteoarthritis (OA), sponsored by Cellular Biomedicine Group. Started Jul 2023; status: active.
02
Drugs
allogeneic adipose-derived stromal/stem cells
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20232083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232083.